- Home
- LGI vs SMTI Comparison
LGI vs SMTI Comparison
Compare LGI & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LGI | SMTI |
|---|---|---|
| Founded | 2004 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 226.0M | 182.6M |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | LGI | SMTI |
|---|---|---|
| Price | $17.59 | $20.59 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $34.00 |
| AVG Volume (30 Days) | ★ 63.8K | 60.4K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | ★ 7.10% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,586,976.00 |
| Revenue This Year | N/A | $17.31 |
| Revenue Next Year | N/A | $12.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 32.47 |
| 52 Week Low | $13.95 | $16.05 |
| 52 Week High | $19.88 | $35.70 |
Technical Indicators
Market Signals| Indicator | LGI | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 56.44 | 62.39 |
| Support Level | $17.19 | $20.12 |
| Resistance Level | $17.75 | $21.14 |
| Average True Range (ATR) | 0.35 | 1.04 |
| MACD | 0.20 | 0.46 |
| Stochastic Oscillator | 96.71 | 75.76 |
Price Performance
Historical ComparisonAbout LGI Lazard Global Total Return and Income Fund
Lazard Global Total Return & Inc Fd Inc is a United States-based diversified, closed-end management investment company. Its investment objective is total return consisting of capital appreciation and income. The fund's portfolio of investments consists of different sector investments such as consumer staples, financials, consumer discretionary, healthcare, materials, sovereign debt and others.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.